Whelton P K, Lee J Y, Kusek J W, Charleston J, DeBruge J, Douglas M, Faulkner M, Greene P G, Jones C A, Kiefer S, Kirk K A, Levell B, Norris K, Powers S N, Retta T M, Smith D E, Ward H
NIDDK, NIH, Bethesda, MD 20892-6600, USA.
Control Clin Trials. 1996 Aug;17(4 Suppl):17S-33S. doi: 10.1016/s0197-2456(96)00087-6.
Several approaches for recruitment of African American adults with renal insufficiency due to hypertension (glomerular filtration rate between 25 and 70 ml/min/1.73 m2) were explored in the Pilot Study for the African American Study of Kidney Disease and Hypertension (AASK). Over a period of 42 weeks, prescreening information was obtained on 2880 individuals, of whom 498 (17%) were evaluated at a screening visit. Two hundred and twenty-five (8%) had an 125I-iothalamate assessment of glomerular filtration rate. Ninety-four of 97 participants who met all the study eligibility criteria were enrolled in the trial. The most common reasons for ineligibility during screening were absence of renal insufficiency or hypertension, presence of diabetes mellitus, and a body mass index above the acceptable level. Overall, an average of 31 prescreen contacts and 8 screening visits were conducted for every randomization (3.3% yield from prescreening to randomization). Screening in clinical practice was the most efficient method for recruitment (12.6% yield from prescreen contact to randomization compared to 1.1% from mass mailing campaigns, 1.3% from mass media campaigns, and 1.7% from referrals by patients with end-stage renal disease). Randomization yields increased with progressively higher age ranges (2.4%, 3.3%, and 6.0% prescreen to randomization yields for those aged < or = 50, 51-60, and 61-70, respectively). A slight majority (51%) of the prescreen contacts were women, but 75% of the randomized participants were men. Our results suggest that clinic-based screening is an effective approach for recruitment of African Americans with hypertension and renal insufficiency into clinical trials. They also suggest that enrollment of African American women in such studies is a special challenge.
非裔美国人肾脏疾病与高血压研究(AASK)的初步研究探索了几种招募因高血压导致肾功能不全(肾小球滤过率在25至70毫升/分钟/1.73平方米之间)的非裔美国成年人的方法。在42周的时间里,获取了2880人的预筛查信息,其中498人(17%)在筛查访视时接受了评估。225人(8%)进行了碘他拉酸125I肾小球滤过率评估。符合所有研究入选标准的97名参与者中有94人被纳入试验。筛查期间不符合入选标准的最常见原因是不存在肾功能不全或高血压、患有糖尿病以及体重指数高于可接受水平。总体而言,每次随机分组平均进行31次预筛查接触和8次筛查访视(从预筛查到随机分组的成功率为3.3%)。临床实践中的筛查是最有效的招募方法(从预筛查接触到随机分组的成功率为12.6%,相比之下,大规模邮寄活动的成功率为1.1%,大众媒体活动的成功率为1.3%,终末期肾病患者转诊的成功率为1.7%)。随机分组成功率随着年龄范围的逐渐升高而增加(年龄≤50岁、51 - 60岁和61 - 70岁的人群从预筛查到随机分组的成功率分别为2.4%、3.3%和6.0%)。预筛查接触者中略多数(51%)为女性,但随机分组的参与者中有75%为男性。我们的结果表明,基于诊所的筛查是将患有高血压和肾功能不全的非裔美国人招募到临床试验中的有效方法。它们还表明,让非裔美国女性参与此类研究是一项特殊挑战。